|
Report No. : |
348491 |
|
Report Date : |
09.11.2015 |
IDENTIFICATION DETAILS
|
Name : |
FARMABIOT S.A. DE C.V. |
|
|
|
|
Registered Office : |
Calle 2 L-1 Mz Vi
S/N, Toluca De Lerdo, Estado de México 50200 |
|
|
|
|
Country : |
Mexico |
|
|
|
|
Year of Establishment : |
1997 |
|
|
|
|
Legal Form : |
Sociedad Anónima de Capital Variable |
|
|
|
|
Line of Business : |
Pharmaceutical Manufacturing Industry |
|
|
|
|
No. of Employee : |
50 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Mexico |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
MEXICO - ECONOMIC OVERVIEW
Mexico's $1.3 trillion economy has become increasingly oriented toward manufacturing in the 21 years since the North American Free Trade Agreement (NAFTA) entered into force. Per capita income is roughly one-third that of the US; income distribution remains highly unequal. Mexico has become the United States' second-largest export market and third-largest source of imports. In 2014, two-way trade in goods and services exceeded $550 billion. Mexico has free trade agreements with 46 countries, putting more than 90% of trade under free trade agreements. In 2012, Mexico formally joined the Trans-Pacific Partnership negotiations and formed the Pacific Alliance with Peru, Colombia and Chile. Mexico's current government, led by President Enrique PENA NIETO, emphasized economic reforms during its first two years in office, passing and implementing sweeping education, energy, financial, fiscal and telecommunications reform legislation, among others, with the long-term aim to improve competitiveness and economic growth across the Mexican economy. Although the economy is expected to experience stronger growth in 2015 as a result of increased investment and stronger demand for Mexican exports, growth is predicted to remain below potential for reasons of inefficiencies, with a large portion of the economy and workforce in the informal sector, and corruption. Over the medium-term, the economy is vulnerable to global economic pressures, such as lower external demand, rising interest rates, and low oil prices - approximately 30% of government revenue comes from the state-owned oil company, PEMEX. The increasing integration of supply chains, development of the energy sector, and government-to-government focus on trade facilitation will continue to make the North American region increasingly competitive and contribute to Mexican economic development and strength.
|
Source
: CIA |
STATUTORY INFORMATION
|
|
|
|
|
|
Legal Name: |
FARMABIOT S.A.
DE C.V. |
|
Trade Name: |
FARMABIOT |
|
RFC: |
FAR9702117V4 |
|
Date Created: |
1997 |
|
Date Incorporated: |
1997 |
|
Legal Address: |
Calle 2 L-1 Mz
Vi S/N |
|
Operative Address: |
Calle 2 L-1 Mz
Vi S/N |
|
Telephone: |
52 722 279 0048 |
|
Fax: |
52 722 279 0048 |
|
Legal Form: |
Sociedad Anónima
de Capital Variable |
|
Email: |
|
|
Registered in: |
Mexico |
|
Website: |
|
|
Contact: |
Jesús Medina,
Director |
|
Staff: |
50 |
|
Activity: |
Pharmaceutical
Manufacturing Industry |
|
|
|
BANKS
BANAMEX The company
does not make its banking data public |
|
|
|
|
History
The company was founded in 1997 |
|
|
|
|
PRINCIPAL ACTIVITY
|
|
|
|
Company
dedicated to the commercialization of products for the health care. |
|
Products/Services description: |
Pharmaceutical
Products |
|
Brands: |
ACCOCIT |
|
Sales are: |
Wholesale |
|
Clients: |
Pharmaceutical
Industry |
|
Suppliers: |
FABTECH
TECHNOLOGIES INTERNATIONAL |
|
Operations area: |
National |
|
The company imports from |
India |
|
The company exports to |
No exports |
|
The subject employs |
50 employees |
|
Payments: |
Regular |
|
|
|
|
|
|
LOCATION
|
|
|
Headquarters : |
Calle 2 L-1 Mz
Vi S/N |
|
Branches: |
The company
does not have branches |
|
Related companies: |
Accord Farma,
S.A. de C.V |
|
|
|
GROUP
STRUCTURE AND SUBSIDIARY COMPANIES
|
|
|
Listed at the stock exchange: |
NA |
|
Capital: |
NO |
|
Shareholders: |
This is a
private company. We could not confirm shareholders. |
|
Management: |
Hasmukhbhai
Chundgar Nimishbhai, Presidente |
|
|
|
|
|
|
FINANCIAL INFORMATION
|
|
|
This is a private company which does not
make its financials public. |
|
|
USD 2014 |
|
|
Revenue |
2 100 000 |
|
Cash Flow |
Normal |
|
|
|
LEGAL FILINGS
|
|
|
|
|
|
There are no legal connected to the subject |
|
|
|
|
|
|
|
SUMMARY
|
|
|
Company
dedicated to the commercialization of products for the health care. It has 17 years
of experience in the market with a small-medium sized structure. The company has
a sister company and mainly imports from India. There are no
negative. |
|
|
|
|
RISK INFORMATION
|
|
|
DEBTS |
Controlled |
|
PAYMENTS |
No Complaint |
|
CASH FLOW |
Normal |
|
STATUS |
Active |
|
|
|
|
INTERVIEW |
|
|
NAME |
NA |
|
POSITION |
Administrative |
|
COMMENTS |
She confirmed address,
related company, staff and activity. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.65.79 |
|
|
1 |
Rs.99.95 |
|
Euro |
1 |
Rs.71.55 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
ASH |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.